M. İnanç Et Al. , "Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid," MEDICAL ONCOLOGY , vol.31, no.3, 2014
İnanç, M. Et Al. 2014. Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. MEDICAL ONCOLOGY , vol.31, no.3 .
İnanç, M., KAYNAR, L., Enhoş, S., Pala, C., Karaca, H., Berk, V., ... ÖZKAN, M.(2014). Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. MEDICAL ONCOLOGY , vol.31, no.3.
İnanç, MEVLÜDE Et Al. "Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid," MEDICAL ONCOLOGY , vol.31, no.3, 2014
İnanç, MEVLÜDE Et Al. "Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid." MEDICAL ONCOLOGY , vol.31, no.3, 2014
İnanç, M. Et Al. (2014) . "Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid." MEDICAL ONCOLOGY , vol.31, no.3.
@article{article, author={MEVLÜDE İNANÇ Et Al. }, title={Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid}, journal={MEDICAL ONCOLOGY}, year=2014}